344 related articles for article (PubMed ID: 9375705)
1. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
Decaux G; Prospert F; Namias B; Soupart A
Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
[TBL] [Abstract][Full Text] [Related]
2. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance.
Decaux G; Namias B; Gulbis B; Soupart A
J Am Soc Nephrol; 1996 May; 7(5):805-10. PubMed ID: 8738818
[TBL] [Abstract][Full Text] [Related]
3. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.
Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A
Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630
[TBL] [Abstract][Full Text] [Related]
4. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
[TBL] [Abstract][Full Text] [Related]
5. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
7. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
Kotnik P; Nielsen J; Kwon TH; Krzisnik C; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2005 May; 288(5):F1053-68. PubMed ID: 15644490
[TBL] [Abstract][Full Text] [Related]
10. A comparison of diagnostic methods to differentiate diabetes insipidus from primary polyuria: a review of 21 patients.
Milles JJ; Spruce B; Baylis PH
Acta Endocrinol (Copenh); 1983 Dec; 104(4):410-6. PubMed ID: 6659843
[TBL] [Abstract][Full Text] [Related]
11. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
12. Low serum urea level in dehydrated patients with central diabetes insipidus.
Comtois R; Bertrand S; Beauregard H; Vinay P
CMAJ; 1988 Nov; 139(10):965-9. PubMed ID: 3179869
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults.
Diederich S; Eckmanns T; Exner P; Al-Saadi N; Bähr V; Oelkers W
Clin Endocrinol (Oxf); 2001 May; 54(5):665-71. PubMed ID: 11380498
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.
Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA
Nephron; 1990; 54(4):322-6. PubMed ID: 2109264
[TBL] [Abstract][Full Text] [Related]
15. [Serum Uric Acid Level and Its Influencing Factors in Patients with Diabetes Insipidus].
Wang SH; Zhu HJ; Duan L; Ping F; Wang X; Chi Y; Yuan T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):44-49. PubMed ID: 36861154
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes insipidus: etiology, diagnosis, and therapy].
Laczi F
Orv Hetil; 2002 Nov; 143(46):2579-85. PubMed ID: 12520852
[TBL] [Abstract][Full Text] [Related]
17. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.
Posner L; Mokrzycki MH
Am J Nephrol; 1996; 16(4):339-43. PubMed ID: 8739289
[TBL] [Abstract][Full Text] [Related]
18. Gestational diabetes insipidus: Diagnosis and management.
Ananthakrishnan S
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
[TBL] [Abstract][Full Text] [Related]
19. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
[TBL] [Abstract][Full Text] [Related]
20. Animal models for diabetes insipidus.
Mahía J; Bernal A
Handb Clin Neurol; 2021; 181():275-288. PubMed ID: 34238463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
